Tutorials
HilleVax Inc logo

HilleVax Inc

$ 12.31 -0.64 (-4.94%) 11:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 411.49M
Enterprise V:
$ 497.15M
Volume:
20.01K
Avg Vol (2M):
152.48K
Volume:
20.01K
Market Cap $:
411.49M
PE Ratio:
At Loss
Avg Vol (2-Month):
152.48K
Enterprise Value $:
497.15M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

HilleVax Inc
NAICS : 541714 SIC : 2834
75 State Street, Suite 100 - 9995, Boston, MA, USA, 02109
Description
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset -0.79
Debt-to-Equity -1.57
Debt-to-EBITDA -1.59
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 42.02
9-Day RSI 46.41
14-Day RSI 48.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.55
Quick Ratio 0.55
Cash Ratio 0.55

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROA % -160.43
ROIC % -14.32
ROC (Joel Greenblatt) % -43101.3

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -4.74
EV-to-EBITDA -4.74
EV-to-FCF -49.21
Earnings Yield (Greenblatt) % -21.05

Financials (Next Earnings Date:2022-08-31 Est.)

HLVX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HLVX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -3.28
Beta 0
Volatility % 0
14-Day RSI 48.28
14-Day ATR ($) 1.242019
20-Day SMA ($) 12.792
12-1 Month Momentum % 0
52-Week Range ($) 7.9 - 20.95
Shares Outstanding (Mil) 33.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HilleVax Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More